Common Contracts

Asset purchase agreement for follow-on biologics platform‌‌‌‌

Asset Purchase Agreement • December 16th, 2010

• Contract Type
  Asset Purchase Agreement
• Filed
  December 16th, 2010

Merck will purchase all assets related to Insmed's follow-on biologics platform. Insmed will receive a total of $130 million for the assets.

ASSET PURCHASE AGREEMENT Dated as of February 12, 2009 among PROTEIN TRANSACTION, LLC, a wholly-owned subsidiary of MERCK & CO., INC., INSMED INCORPORATED and MERCK & CO., INC.,

Asset Purchase Agreement • February 13th, 2009 • Insmed Inc • Pharmaceutical preparations

• Contract Type
  Asset Purchase Agreement
• Filed
  February 13th, 2009
• Company
  Insmed Inc
• Industry
  Pharmaceutical preparations